Skip to content

A Study of Retatrutide (LY3437943) Once Weekly in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee

Obesity | Overweight | Osteo Arthritis Knee

The main purpose of this study is to evaluate the safety and efficacy of retatrutide once-weekly in participants who have obesity or are overweight and have osteoarthritis (OA) of the knee. The study will lasts about 77 weeks.

null

Participation Requirements

  • Sex:

    ALL
  • Eligible Ages:

    18 and up

Participation Criteria

Inclusion Criteria:

* Have a body mass index (BMI) ≥27 kilogram/kg/m² at screening.
* Have a history of at least 1 self-reported unsuccessful dietary effort to lose body weight.
* Have index knee pain for \>12 weeks prior to screening, and presence of index knee pain for \>15 days over the previous month.
* Have knee X-ray with moderate radiographic changes (Kellgren-Lawrence Grade 2 or 3) per central reading at screening.
* Currently meets American College of Rheumatology (ACR) Criteria (clinical and radiological) for OA.

Exclusion Criteria:

* Have had steroid joint injections within 90 days of screening.
* Have had other joint injections and procedures within 6 months of screening.
* Have joint disease other than osteoarthritis.
* Have a self-reported or documented change in body weight \>5 kg (11 pounds) within 90 days prior to screening.
* Have been taking weight loss drugs, including over-the-counter medications, within 90 days prior to screening.
* Have a prior or planned surgical treatment for obesity.
* Have diabetes mellitus.

Study Location

Wharton Medical Clinic
Wharton Medical Clinic
Hamilton, Ontario
Canada

Contact Study Team

Canadian Phase Onward
Canadian Phase Onward
Toronto, Ontario
Canada

Contact Study Team

Viable Clinical Research
Viable Clinical Research
Bridgewater, Nova Scotia
Canada

Contact Study Team

Stouffville Medical Research Institute Inc.
Stouffville Medical Research Institute Inc.
Stouffville, Ontario
Canada

Contact Study Team

C-health Research
C-health Research
Calgary, Alberta
Canada

Contact Study Team

Bluewater Clinical Research Group Inc.
Bluewater Clinical Research Group Inc.
Sarnia, Ontario
Canada

Contact Study Team

Eastern Health - General Hospital
Eastern Health - General Hospital
St. John's, Newfoundland and Labrador
Canada

Contact Study Team

Viable Clinical Research
Viable Clinical Research
Scarborough, Ontario
Canada

Contact Study Team

Study Sponsored By
Eli Lilly and Company
Participants Required
More Information
Study ID: NCT05931367